US Graves’ disease market is growing at a CAGR of around 4.0% during the forecast period. The US Grave’s disease market is showing significant growth due to funding for autoimmune disease researches, and the increasing prevalence of hyperthyroidism in the region. In addition, significant rise in the prevalence of autoimmune disease is also expected to propel the growth of the US Graves’ disease market. According to the American Autoimmune Related Diseases Association, Inc. (AARDA), the number of Americans suffer from autoimmune disease is 50 million. This is approximately 20% of the total population or 1 in 5 people suffer from autoimmune disease. 75% of people that are affected with autoimmune disease, about 30 million are women.

Request a Free Sample of Our Report on US Graves’ Disease Market:https://www.omrglobal.com/request-sample/us-graves-disease-market

Furthermore, as per AARDA, NIH invests $591 million on autoimmune disease research. NIH supports companies in the development of therapies for the treatment of Grave’s. For instance, in December 2017, EpiVax, Inc., a US-based biotech firm declared the latest program for novel antigen-specific therapies. The funding was provided by NIH for development of the therapy. This approach may have applications in various autoimmune diseases.

A Full Report of US Graves’ Disease Market is Available at:https://www.omrglobal.com/industry-reports/us-graves-disease-market

Moreover, hyperthyroidism is the most common disease in the US. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), estimated 1.2% of people in the US have hyperthyroidism. The people that have other health problems, such as type 1 diabetes, primary adrenal insufficiency and pernicious anemia are likely to develop hyperthyroidism. The most common cause of hyperthyroidism is Grave’s disease.

Secondary Sources Include

Financial reports of companies involved in the market.
Whitepapers, research-papers, and news blogs.
Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

US Graves’ Disease by Diagnosis

Ultrasound
Imaging Tests
Radioactive Iodine Uptake
Blood Sample

US Graves’ Disease by Treatment

Anti- Thyroid Medication
Radioactive Iodine Therapy
Surgery

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/us-graves-disease-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404